CNCR Loncar Cancer Immunotherapy ETF
0.00
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About CNCR Loncar Cancer Immunotherapy ETF
The Index tracked by the Fund is the Range Cancer Therapeutics Index, which seeks to achieve the same investment performance as the Index before deducting various fees and expenses. The Fund seeks to invest all or substantially all of its assets in the constituent securities and ADRs that make up the Index. Under normal circumstances, at least 80% of the fund's total assets (excluding any collateral held for securities borrowing) will be invested in the constituent securities of the index.
Trade GPT
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.